Irbesartan Sandoz (Irbesartan)

Irbesartan selectively blocks AT1 receptors, preventing angiotensin II‑mediated vasoconstriction and aldosterone secretion. This results in vasodilation, reduced sodium and water retention, and ultimately lower systemic blood pressure.

The prescribed dose of irbesartan is determined by the treating physician based on the individual’s clinical condition, blood pressure response, and renal function. Patients should follow the dosage instructions provided by their healthcare professional.

Safety of irbesartan in pregnancy has not been established, and it is generally avoided because of potential fetal risk. Limited data are available for breastfeeding; the decision to use it should be made by a physician after weighing benefits and risks.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure reduction similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers or diuretics, ARBs provide a distinct mechanism focused on the renin‑angiotensin system.

Irbesartan Sandoz tablets should be stored below 25 °C, in the original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Irbesartan Sandoz is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their clinician.

Serious risks include angioedema, which can cause swelling of the face or throat, hyperkalemia that may lead to cardiac arrhythmias, and acute renal impairment, especially in patients with pre‑existing kidney disease or when combined with other nephrotoxic agents.

Irbesartan is contraindicated in patients with known hypersensitivity to the drug, those with severe hepatic impairment, and it should be avoided during pregnancy. Caution is advised for individuals with severe renal dysfunction or electrolyte disturbances.